Related Experiment Video
Updated: Aug 9, 2026

Quantitative Comparison of cis-Regulatory Element (CRE) Activities in Transgenic Drosophila melanogaster
Published on: December 19, 2011
Expression and transcriptional activity of AP-1, CRE, and URE binding proteins in B16 mouse melanoma subclones
S E Rutberg1, I M Goldstein, Y M Yang
1Molecular Carcinogenesis Program, American Health Foundation, Valhalla, New York.
Abstract:
The expression and DNA binding activity of members of the activating protein-1 (AP-1) and activating transcription factor (ATF) families of transcription factors were analyzed in sham and ultraviolet (UV)-irradiated subclones of the B16 mouse melanoma cell system. The four subclones we used represent sequential stages in the development and progression of malignant melanoma and exhibit differences in growth and metastatic potential. Western blot analysis revealed differential expression of some AP-1 (c-jun, jun-B, and jun-D) and ATF (43- and 47-kDa cyclic AMP-responsive element binding protein (CREB) family members) in the different subclones; while c-jun expression was noted in the subclones with the greater malignant potential, jun-D was expressed in those with the lesser malignant potential. Furthermore, a delicate balance between the two forms of CREB was noted; the 47-kDa CREB appeared, when expressed exclusively, in subclones that exhibit a greater malignant potential. Electrophoretic mobility shift assays using AP-1, CRE, and UV-responsive element (URE) consensus sequences indicated that distinct complexes were formed with extracts from each of the four subclones. The complexes were competitively inhibited by each of the target sequences used, suggesting that "cross-talk" occurs between some AP-1 and ATF family members in this cell system. Moreover, a multimer of the URE sequence, cloned upstream of a chloramphenicol acetyltransferase reporter gene, was transcriptionally active and responsive to UV irradiation in two of the four subclones. UV-related transcriptional activation was directly correlated with the expression of a 43-kDa CREB. Together, these observations identify members of AP-1 and CREB families whose expression and activities correlate with the malignant potential of subclones that represent different stages in melanoma development and progression.
Insights
Activating protein-1 (AP-1) and cyclic AMP-responsive element binding protein (CREB) family members
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Melanoma progression involves complex transcriptional regulation.
- Activating protein-1 (AP-1) and activating transcription factor (ATF) families are key regulators.
- Understanding their roles in melanoma subtypes is crucial for targeted therapies.
Purpose of the Study:
- To investigate the expression and DNA binding activity of AP-1 and ATF family members in distinct melanoma cell subclones.
- To correlate the activity of these transcription factors with melanoma malignancy and metastatic potential.
- To examine the impact of ultraviolet (UV) irradiation on transcriptional activity.
Main Methods:
- Western blot analysis to assess protein expression levels of AP-1 and ATF members.
- Electrophoretic mobility shift assays (EMSA) to evaluate DNA binding activities.
- Reporter gene assays using UV-responsive elements (URE) to measure transcriptional activity.
Main Results:
- Differential expression of c-jun, jun-B, jun-D, and cyclic AMP-responsive element binding protein (CREB) variants (43-kDa and 47-kDa) was observed across melanoma subclones.
- Specific AP-1 and CREB members correlated with increased malignant potential and metastatic capacity.
- UV irradiation induced transcriptional activation of URE-driven reporter genes, linked to 43-kDa CREB expression.
Conclusions:
- Expression patterns and DNA binding activities of AP-1 and CREB family members are associated with melanoma progression stages.
- A balance between CREB isoforms (43-kDa vs. 47-kDa) may dictate melanoma malignancy.
- These findings highlight specific AP-1 and CREB factors as potential biomarkers and therapeutic targets in melanoma.
Related Concept Videos
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Master Transcription Regulators
Abnormal Proliferation

